Blank Rome Represents Think Equity in Connection with a $69M Follow-On Public Offering of Lantern Pharma, Inc. Common Stock
Blank Rome represented Think Equity as representative of the underwriters in connection with a $69.0M follow-on public offering of Lantern Pharma Inc. common stock. Lantern is a clinical stage biotechnology company, focused on leveraging artificial intelligence (“A.I.”), machine learning and genomic data to streamline the drug development process and to identify the patients that will benefit from our targeted oncology therapies. The Blank Rome team was led by Brad Shiffman and Elena Jacque. The transaction closed on January 20, 2021.